These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38861774)

  • 1. Establishment of a human induced pluripotent stem cell line from a patient with dilated cardiomyopathy.
    Ye L; Ni B; Wu H; Han X; Li H; Liu J; Hu S; Lei W
    Stem Cell Res; 2024 Aug; 78():103467. PubMed ID: 38861774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human induced pluripotent stem cell line YCMi007-A generated from a dilated cardiomyopathy patient with a heterozygous dominant c.613C > T (p. Arg205Trp) variant of the TNNT2 gene.
    Jeon SB; Kim H; Chun KH; Oh J; Kwon C; Choi HK; Kim S; Kim HP; Kim IC; Yoo JY; Park SW; Kang SM; Lee SH
    Stem Cell Res; 2023 Mar; 67():103048. PubMed ID: 36801602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a heterozygous FLNC mutation-carrying human iPSC line, USFi002-A, for modeling dilated cardiomyopathy.
    Argenziano MA; Burgos Angulo M; Najari Beidokhti M; Yang J; Bertalovitz AC; McDonald TV
    Stem Cell Res; 2021 May; 53():102394. PubMed ID: 34088019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
    Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC
    Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations.
    Kojic A; Kim H; Guevara JV; Ravada S; Sallam K; Wu JC
    Stem Cell Res; 2022 Oct; 64():102928. PubMed ID: 36194907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of YCMi005-A, a human-induced pluripotent stem cell line, from a patient with dilated cardiomyopathy carrying missense variant in TPM1 (p. Glu192Lys).
    Cha YJ; Jeon SB; Oh J; Lee ST; Kim S; Kim H; Choi J; Choi HK; Won D; Choi JR; Kim SJ; Park SW; Kang SM; Lee SH
    Stem Cell Res; 2022 Apr; 60():102707. PubMed ID: 35176663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Genetic Variants in BAG3 and TNNT2 in a Swedish Family with a History of Dilated Cardiomyopathy and Sudden Cardiac Death.
    Fernlund E; Österberg AW; Kuchinskaya E; Gustafsson M; Jansson K; Gunnarsson C
    Pediatr Cardiol; 2017 Aug; 38(6):1262-1268. PubMed ID: 28669108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients.
    Caudal A; Mondejar-Parreño G; Vera CD; Williams DR; Shenoy SP; Liang D; Wu JC
    Stem Cell Res; 2022 Aug; 63():102855. PubMed ID: 35853412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
    Perea-Gil I; Seeger T; Bruyneel AAN; Termglinchan V; Monte E; Lim EW; Vadgama N; Furihata T; Gavidia AA; Arthur Ataam J; Bharucha N; Martinez-Amador N; Ameen M; Nair P; Serrano R; Kaur B; Feyen DAM; Diecke S; Snyder MP; Metallo CM; Mercola M; Karakikes I
    Eur Heart J; 2022 Sep; 43(36):3477-3489. PubMed ID: 35728000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a human iPSC (ZZUNEUi026-A) from a dilated cardiomyopathy patient carrying heterozygous Vinculin (c. 625A > T) mutant.
    Liu Y; Li X; Zhao X; Dong J; Zhang C; Lin T
    Stem Cell Res; 2022 Jul; 62():102812. PubMed ID: 35567849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations.
    Zhang TT; Zhao SR; Alamana C; Shen M; Parikh V; Wheeler MT; Wu JC
    Stem Cell Res; 2022 Dec; 65():102941. PubMed ID: 36270069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy.
    Mogensen J; Murphy RT; Shaw T; Bahl A; Redwood C; Watkins H; Burke M; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Nov; 44(10):2033-40. PubMed ID: 15542288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
    Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
    Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients caused by heterozygous mutations in the HCN4 gene.
    Yildirim Z; Kojic A; Yan CD; Wu MA; Vagelos R; Wu JC
    Stem Cell Res; 2022 Dec; 65():102951. PubMed ID: 36332467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.
    Wu H; Lee J; Vincent LG; Wang Q; Gu M; Lan F; Churko JM; Sallam KI; Matsa E; Sharma A; Gold JD; Engler AJ; Xiang YK; Bers DM; Wu JC
    Cell Stem Cell; 2015 Jul; 17(1):89-100. PubMed ID: 26095046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a patient-specific iPSC cell line with cardiac arrhythmias and dilated cardiomyopathy (CBRCULi016-A), an isogenic control (CBRCULi016-A-1), and a paternal control (CBRCULi017-A).
    Djemai M; Jauvin D; Poulin H; Chapotte-Baldacci CA; Chahine M
    Stem Cell Res; 2024 Mar; 75():103308. PubMed ID: 38232626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of
    Shah D; Virtanen L; Prajapati C; Kiamehr M; Gullmets J; West G; Kreutzer J; Pekkanen-Mattila M; Heliö T; Kallio P; Taimen P; Aalto-Setälä K
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation.
    Maurer W; Rebs S; Köhne S; Eberl H; Wollnik B; Zibat A; Streckfuss-Bömeke K
    Stem Cell Res; 2024 Jun; 77():103409. PubMed ID: 38583294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac troponin T (TNNT2) mutations in chinese dilated cardiomyopathy patients.
    Li X; Luo R; Gu H; Deng Y; Xu X; Wu X; Hua W
    Biomed Res Int; 2014; 2014():907360. PubMed ID: 25110706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.
    Ahmad F; Banerjee SK; Lage ML; Huang XN; Smith SH; Saba S; Rager J; Conner DA; Janczewski AM; Tobita K; Tinney JP; Moskowitz IP; Perez-Atayde AR; Keller BB; Mathier MA; Shroff SG; Seidman CE; Seidman JG
    PLoS One; 2008 Jul; 3(7):e2642. PubMed ID: 18612386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.